Progress in non-pharmacological strategies of heart failure with preserved ejection fraction
10.3969/j.issn.1004-8812.2024.09.007
- VernacularTitle:射血分数保留的心力衰竭非药物治疗进展
- Author:
Xiao-Ming XU
1
;
Yun-Long XIA
;
Lin-Ying XIA
;
Yong-Zhen GUO
;
Quan-Chi LIU
;
Xue HAN
;
Wen-Jun YAN
Author Information
1. 中国人民解放军空军军医大学第一附属医院(西京医院)心血管内科,陕西西安 710032
- Keywords:
Heart failure with preserved ejection fraction;
Non-pharmacological treatments;
Device-based therapy;
Monitoring and pre-warning
- From:
Chinese Journal of Interventional Cardiology
2024;32(9):528-534
- CountryChina
- Language:Chinese
-
Abstract:
Heart failure with preserved ejection fraction(HFpEF)is a highly heterogeneous systemic condition and represents the predominant form of heart heart failure(HF)worldwide.Current pharmacotherapies for HFpEF are limited and lack specific targeted drugs.Recent studies suggest that non-pharmacological strategies serve as adjuncts to conventional pharmacological treatment,offering improvements in symptoms,quality of life,and reducing the risk of rehospitalization for HF in patients with HFpEF.These strategies include CD34 stem cell transplantation,the greater splanchnic nerve ablation,atrial septal shunting,atrial pacing,myocardial contractility modulation,left ventricular expander,baroreceptor stimulation,and others.This review comprehensively summarizes the latest clinical evidence on non-pharmacological treatments for HFpEF,with the aim of advancing the understanding of treatment strategies for this condition.
